Patent Application Titled "Autoimmune Suppressor And Application Thereof" Published Online (USPTO 20240092920).
In: Respiratory Therapeutics Week, 2024-04-14, S. 2904-2904
serialPeriodical
Zugriff:
The US Patent and Trademark Office has published a patent application titled "Autoimmune Suppressor And Application Thereof" by Keymed Biosciences Co. Ltd. in Chengdu, China. The patent application describes an antibody that specifically binds to IL-4Ra, a receptor involved in immune responses. The antibody has high specificity and affinity for IL-4Ra and inhibits its binding to IL-4 and IL-13. The invention aims to develop a therapeutic antibody for treating diseases associated with IL-4Ra, such as asthma, atopic dermatitis, and allergic rhinitis. Extensive research has shown promising results without visible side effects. The patent application includes claims specifying the amino acid sequences of the antibody's heavy and light chain variable regions. [Extracted from the article]
Copyright of Respiratory Therapeutics Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Patent Application Titled "Autoimmune Suppressor And Application Thereof" Published Online (USPTO 20240092920).
|
---|---|
Zeitschrift: | Respiratory Therapeutics Week, 2024-04-14, S. 2904-2904 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1543-6659 (print) |
Schlagwort: |
|
Sonstiges: |
|